Clinical Trial Update: Biomarkers in Samples From Patients With B-Cell Acute Lymphoblastic Leukemia

View source ↗

Summary

The update summarizes biomarker analyses performed on samples from patients with B-cell acute lymphoblastic leukemia. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Leukemia | Status: COMPLETED